Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Revesz

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Neurology|April 24, 2002
Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutationJ C Janssen, E K Warrington, H R Morris, et al.
The Journal of Biological Chemistry|September 15, 2001
Systemic amyloid deposits in familial British dementiaJ A Ghiso, J Holton, L Miravalle, et al.
Neuropathology and Applied Neurobiology|September 16, 2006
Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological studyT Lashley, J L Holton, M M Verbeek, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2002
Sequence analysis of tau in familial and sporadic progressive supranuclear palsyH R Morris, R Katzenschlager, J C Janssen, et al.
Brain Research. Molecular Brain Research|June 14, 2005
Quantitative analysis of tau isoform transcripts in sporadic tauopathiesJ W Connell, T Rodriguez-Martin, G M Gibb, et al.
Brain : a Journal of Neurology|May 20, 2005
Brain biopsy in dementiaJ D Warren, J M Schott, N C Fox, et al.
Neuropathology and Applied Neurobiology|June 6, 2003
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodiesR de Silva, T Lashley, G Gibb, et al.
The American Journal of Pathology|February 13, 2001
Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementiaJ L Holton, J Ghiso, T Lashley, et al.
Neuropathology and Applied Neurobiology|June 24, 2011
LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative studyS Sharma, R Bandopadhyay, T Lashley, et al.
Neuroimage. Clinical|December 17, 2016
9.4 T MR microscopy of the substantia nigra with pathological validation in controls and diseaseL A Massey, M A Miranda, O Al-Helli, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Neurology|April 24, 2002
Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutationJ C Janssen, E K Warrington, H R Morris, et al.
The Journal of Biological Chemistry|September 15, 2001
Systemic amyloid deposits in familial British dementiaJ A Ghiso, J Holton, L Miravalle, et al.
Neuropathology and Applied Neurobiology|September 16, 2006
Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological studyT Lashley, J L Holton, M M Verbeek, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2002
Sequence analysis of tau in familial and sporadic progressive supranuclear palsyH R Morris, R Katzenschlager, J C Janssen, et al.
Brain Research. Molecular Brain Research|June 14, 2005
Quantitative analysis of tau isoform transcripts in sporadic tauopathiesJ W Connell, T Rodriguez-Martin, G M Gibb, et al.
Brain : a Journal of Neurology|May 20, 2005
Brain biopsy in dementiaJ D Warren, J M Schott, N C Fox, et al.
Neuropathology and Applied Neurobiology|June 6, 2003
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodiesR de Silva, T Lashley, G Gibb, et al.
The American Journal of Pathology|February 13, 2001
Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementiaJ L Holton, J Ghiso, T Lashley, et al.
Neuropathology and Applied Neurobiology|June 24, 2011
LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative studyS Sharma, R Bandopadhyay, T Lashley, et al.
Neuroimage. Clinical|December 17, 2016
9.4 T MR microscopy of the substantia nigra with pathological validation in controls and diseaseL A Massey, M A Miranda, O Al-Helli, et al.
Pageof 14